Tricida Inc is a clinical-stage pharmaceutical company focused on discovering and developing novel non-absorbed therapies for renal, metabolic, and cardiovascular diseases, particularly targeting metabolic acidosis in chronic kidney disease
Tricida Inc is a clinical-stage pharmaceutical company focused on discovering and developing novel non-absorbed therapies for renal, metabolic, and cardiovascular diseases, particularly targeting metabolic acidosis in chronic kidney disease.
The top three firms on F4's Biotech & Life Sciences investor list.